Related Experiment Video
Updated: Apr 18, 2026
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.3K
Biosimilars: clinical interpretation and implications for drug development.
1Organización Médica de Investigación, Buenos Aires, Argentina, e.mysler@omiargentina.com.ar.
Current Rheumatology Reports
|January 26, 2015
Summary
Biosimilars are now available in Europe, changing how severe conditions are treated, especially in rheumatology. Understanding their clinical trials is key for physicians to assess efficacy and safety.
Area of Science:
- Pharmacology
- Rheumatology
- Drug Development
Background:
- European Medicines Agency approval of biosimilars marks a significant market shift.
- Biosimilars are crucial in rheumatology due to patent expirations of original biologics.
- Physicians need to understand biosimilar clinical trials for effective patient treatment.
Purpose of the Study:
- To summarize the clinical development of biosimilars.
- To review the efficacy and safety profiles of biosimilar medications.
- To guide physicians in the clinical application of biosimilars.
Main Methods:
- Review of clinical trial methodologies for biosimilars.
- Analysis of non-inferiority trial designs for biosimilar evaluation.
- Assessment of efficacy and safety data from biosimilar studies.
Main Results:
- Biosimilar clinical trials focus on demonstrating no significant difference in efficacy and safety compared to reference biologics.
- These trials are essential for regulatory approval and physician confidence.
- The data supports the interchangeability and therapeutic equivalence of biosimilars.
Conclusions:
- Biosimilars represent a new era in treating severe conditions, particularly in rheumatology.
- Physicians must interpret specific clinical trial data to safely and effectively integrate biosimilars.
- The development and approval process ensures biosimilars offer comparable therapeutic benefits to originator biologics.
More Related Videos
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
361
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
361
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
221
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
221
01:16Bioequivalence: Overview
2.3K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.3K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
285
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
285
01:16Bioequivalence Data: Statistical Interpretation
345
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
345
01:28Biopharmaceutics and Pharmacokinetics: Overview
5.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.2K